Figure 2.
Fluorescein angiography showing an avascular peripheral retina in a 2-year-old child born preterm (25 weeks of gestational age, birth weight 650 g) and treated with 0.2 mg/0.02 mL of ranibizumab at 34 weeks of postmenstrual age for type 1 retinopathy of prematurity (Courtesy of Dr. Domenico Lepore)